Description

AQUAPHARM CHEMICAL LIMITED has fixed Record Date for payment of interest and part redemption of Non-Convertible Debentures with reduced face value effective from January 13, 2026.

Summary

AQUAPHARM CHEMICAL LIMITED has fixed January 13, 2026 as the Record Date for payment of interest and part redemption of its Non-Convertible Debentures (ISIN: INE0SYQ07015, Code: 975354). Trading in the debentures will commence with reduced face value from the effective date.

Key Points

  • Company: AQUAPHARM CHEMICAL LIMITED
  • ISIN: INE0SYQ07015
  • BSE Code: 975354 (ACL-8.90%-29-1-29-PVT)
  • Record Date: January 13, 2026
  • Purpose: Part Redemption of Debentures and Payment of Interest
  • Reduced Face Value: Rs. 70,000 per Debenture
  • Effective Date: January 13, 2026
  • Settlement Number: DR-797/2025-2026

Regulatory Changes

No regulatory framework changes. This is a standard corporate action for debt securities.

Compliance Requirements

  • Trading Members must note that trading in AQUAPHARM CHEMICAL LIMITED debentures will be conducted with reduced face value of Rs. 70,000 per debenture effective from January 13, 2026
  • All trading and settlement systems must reflect the reduced face value from the effective date
  • Members should update their records and inform clients holding these debentures

Important Dates

  • Notice Date: January 09, 2026
  • Record Date: January 13, 2026
  • Effective Date of Reduced Face Value: January 13, 2026
  • Settlement: DR-797/2025-2026

Impact Assessment

This corporate action has moderate impact on debenture holders and trading members:

  • Debenture Holders: Will receive partial redemption proceeds and interest payment for securities held as of Record Date
  • Trading Impact: Post January 13, 2026, all trades will be executed at the reduced face value of Rs. 70,000 per debenture
  • Operational Impact: Trading members need to update their systems and client records to reflect the reduced face value
  • Market Segment: Affects debt market segment participants dealing with AQUAPHARM CHEMICAL LIMITED debentures

Impact Justification

Part redemption of debentures with reduced face value affects debt security holders of AQUAPHARM CHEMICAL LIMITED, requiring adjustment in trading systems from January 13, 2026.